What is "basiliximab"

n. A monoclonal antibody used to prevent rejection in organ transplantation, especially in kidney transplants.

Basiliximab (trade name Simulect) is a chimeric mouse-human monoclonal antibody to the α chain ( CD25) of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants. It is a Novartis product and was approved by the Food and Drug Administration (FDA) in 1998.